Investigating how genetic variants affect mitochondrial function in type 2 diabetes
Type 2 diabetes risk variant effects on mitochondrial (patho)physiology
This study is looking at how specific genetic differences might affect the health of insulin-producing cells in people with type 2 diabetes, with the goal of finding new ways to help prevent or treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jackson Laboratory NIH-funded |
| Lab location | 1 site (Bar Harbor, United States) |
| Project ID | NIH-11105908 on NIH RePORTER |
What this research studies
This research focuses on understanding how certain genetic variants contribute to the dysfunction of pancreatic beta cells, which are crucial for insulin secretion in type 2 diabetes (T2D). By examining mitochondrial bioenergetics, the study aims to uncover the mechanisms behind beta cell failure and how these genetic factors influence cellular health. The researchers will utilize advanced genomic editing techniques in human islets and mouse models to explore the relationship between genetic variations and mitochondrial function. This approach seeks to provide insights that could lead to new strategies for preventing or treating T2D.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a genetic predisposition to type 2 diabetes or those diagnosed with pre-diabetes.
Not a fit: Patients with type 1 diabetes or those without any genetic risk factors for type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve insulin secretion and mitochondrial health in patients with type 2 diabetes.
How similar studies have performed: Previous research has shown promising results in understanding the genetic factors influencing diabetes, making this approach both relevant and potentially impactful.
Where this research is happening
Bar Harbor, United States
- Jackson Laboratory — Bar Harbor, United States (Active)
Researchers
- Principal investigator: Stitzel, Michael Lee — Jackson Laboratory
- Study coordinator: Stitzel, Michael Lee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.